NCT01204944

Brief Summary

The Swiss Transplant Cohort Study is an observational prospective cohort study enrolling all patients after solid organ and stem cell transplantation since 5/2008 in Switzerland. Predefined variables are collected at defined time points. Individual samples (PBMC, plasma, DNA) will be stored for future projects. Data relevant to transplantation outcome with emphasis on immunological and infectious complications as well as psychosocial variables will be gathered.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,500

participants targeted

Target at P75+ for all trials

Timeline
25mo left

Started May 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
May 2008May 2028

Study Start

First participant enrolled

May 1, 2008

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

September 16, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 17, 2010

Completed
17.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

April 1, 2025

Status Verified

November 1, 2024

Enrollment Period

20 years

First QC Date

September 16, 2010

Last Update Submit

March 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Outcome after transplantation

    Various endpoints

    open

Eligibility Criteria

Age0 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All transplanted indivduals in Switzerland

You may qualify if:

  • All patients after organ and stem cell (planned 2009) transplantation.

You may not qualify if:

  • No informed consent given

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Zurich, Switzerland

RECRUITING

Related Publications (2)

  • Branca-Dragan S, Koller MT, Danuser B, Kunz R, Steiger J, Hug BL. Evolution of disability pension after renal transplantation: methods and results of a database linkage study of the Swiss Transplant Cohort Study and Swiss Disability Insurance. Swiss Med Wkly. 2021 Sep 23;151:w30027. doi: 10.4414/smw.2021.w30027. eCollection 2021 Sep 13.

  • Krisl A, Stampf S, Hauri D, Binet I, Mueller T, Sidler D, Hadaya K, Golshayan D, Pascual M, Koller M, Dickenmann M, The Swiss Transplant Cohort Study Stcs. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study. Swiss Med Wkly. 2020 Dec 5;150:w20354. doi: 10.4414/smw.2020.20354. eCollection 2020 Nov 30.

Biospecimen

Retention: SAMPLES WITH DNA

DNA Plasma PBMC

Study Officials

  • 01 Studienregister MasterAdmins

    UniversitaetsSpital Zuerich

    STUDY DIRECTOR

Central Study Contacts

01 Studienregister MasterAdmins

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head, Zurich University Hospital Transplant Center

Study Record Dates

First Submitted

September 16, 2010

First Posted

September 17, 2010

Study Start

May 1, 2008

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

April 1, 2025

Record last verified: 2024-11

Locations